Vripan 40 Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Vripan 40 Tablet
Gastric acid secretion is diminished by the medication known as AcidoReduce 40mg Tablets. This treatment addresses various gastrointestinal ailments stemming from excess stomach acid, including heartburn, acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and facilitating healing. AcidoReduce 40mg Tablets also serve as a preventative measure against stomach ulcers and hyperacidity potentially induced by long-term pain reliever use. Classified as a proton pump inhibitor (PPI), this medication is optimally ingested one hour prior to meals, ideally in the morning. Dosage is tailored to individual needs and response. Continued use as directed is crucial, even with rapid symptom resolution. Dietary adjustments, such as smaller, more frequent meals, and avoidance of caffeine, spicy, and fatty foods, can enhance therapeutic efficacy. Common, typically mild, adverse effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Persistent or bothersome side effects necessitate medical consultation. Prolonged use, particularly exceeding one year, may elevate the risk of bone fractures, especially at higher doses. Discussions with your physician regarding bone loss prevention strategies, such as calcium and vitamin D supplementation, are recommended. Prior to commencing treatment, disclose any severe liver conditions, concurrent HIV medication use, prior allergic reactions to similar medications, or pre-existing osteoporosis to your doctor. Pregnant or lactating individuals should seek medical advice before initiating AcidoReduce 40mg Tablets.
Primary Ingredients of Vripan 40 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Vripan 40 Tablet
Managing heartburn, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Vripan 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vripan 40 Tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
Common Side effects of Vripan 40 Tablet:
- Diarrhea
- Flatulence
- Headache
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Upper respiratory tract infection
How to use Vripan 40 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vripan 40 Tablet on an empty stomach.
How Vripan 40 Tablet works:
Each Vripan 40 Tablet, a proton pump inhibitor, lessens stomach acid production, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Vripan 40 Tablet.
PregnancyCONSULT YOUR DOCTOR
The use of Vripan 40 Tablet during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the use of Vripan 40 Tablet while breastfeeding is likely safe. Studies in humans indicate minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Vripan 40 Tablet due to potential side effects.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate altered dosing of Vripan 40 Tablet; its use is considered safe in such patients.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vripan 40 Tablet. Dosage modification may be necessary. A physician's consultation is recommended.
What if you forget to take Vripan 40 Tablet :
Should you forget a Vripan 40 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vripan 40 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |





